Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord
- PMID: 7501257
- DOI: 10.1016/0304-3940(95)11839-o
Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord
Abstract
We recently reported that intrathecal administration of prostaglandin E2 induced hyperalgesic and allodynic effects through the glutamate receptor system. Here we examined whether prostaglandin E2 could evoke amino acid release from nerve terminals using rat spinal cord synaptosomes. Exposure in superfusion to prostaglandin E2 significantly increased endogenous glutamate and aspartate release and dose dependencies showed bell-shaped patterns with a peak at 1 nM. Both releases were almost absolutely Ca(2+)-dependent. These results demonstrate that prostaglandin E2 may stimulate the release of excitatory amino acids presynaptically in the spinal cord.
Similar articles
-
Effect of spinal kainic acid receptor activation on spinal amino acid and prostaglandin E2 release in rat.Neuroscience. 1996 Nov;75(2):453-61. doi: 10.1016/0306-4522(96)00294-1. Neuroscience. 1996. PMID: 8931009
-
The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons.Pharmacol Res. 2007 Apr;55(4):255-62. doi: 10.1016/j.phrs.2006.11.010. Epub 2006 Dec 5. Pharmacol Res. 2007. PMID: 17196823
-
Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats.J Neurosci. 1995 Apr;15(4):2768-76. doi: 10.1523/JNEUROSCI.15-04-02768.1995. J Neurosci. 1995. PMID: 7722627 Free PMC article.
-
Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2.J Neurosci. 2004 Feb 11;24(6):1451-8. doi: 10.1523/JNEUROSCI.1517-03.2004. J Neurosci. 2004. PMID: 14960618 Free PMC article.
-
Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamate.Inflamm Res. 1996 Oct;45(10):499-502. doi: 10.1007/BF02311085. Inflamm Res. 1996. PMID: 8912014
Cited by
-
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management.J Neuroinflammation. 2019 Oct 30;16(1):197. doi: 10.1186/s12974-019-1592-3. J Neuroinflammation. 2019. PMID: 31666079 Free PMC article. Review.
-
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.Br J Pharmacol. 2001 Jun;133(3):438-44. doi: 10.1038/sj.bjp.0704092. Br J Pharmacol. 2001. PMID: 11375261 Free PMC article.
-
Methylmercury Neurotoxicity: Exploring Potential Novel Targets.Open Toxicol J. 2007;1:1-9. doi: 10.2174/1874340400701010001. Epub 2007 Oct 17. Open Toxicol J. 2007. PMID: 31178939 Free PMC article.
-
Nitroparacetamol (NCX-701) and pain: first in a series of novel analgesics.CNS Drug Rev. 2007 Fall;13(3):279-95. doi: 10.1111/j.1527-3458.2007.00016.x. CNS Drug Rev. 2007. PMID: 17894645 Free PMC article. Review.
-
Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain.Pain. 2009 Sep;145(1-2):136-41. doi: 10.1016/j.pain.2009.05.029. Epub 2009 Jun 27. Pain. 2009. PMID: 19560866 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous